Rtc-Southeast, Lp is a medicare approved dialysis facility center in Gadsden, Alabama and it has 10 dialysis stations. It is located in Etowah county at 300 Medical Center Drive, Gadsden, AL, 35903. You can reach out to the office of Rtc-Southeast, Lp at (256) 492-4970. This dialysis clinic is managed and/or owned by Davita. Rtc-Southeast, Lp has the following ownership type - Profit. It was first certified by medicare in May, 2013. The medicare id for this facility is 012661 and it accepts patients under medicare ESRD program.
| Name | Rtc-Southeast, Lp |
|---|---|
| Location | 300 Medical Center Drive, Gadsden, Alabama |
| No. of Dialysis Stations | 10 |
| Medicare ID | 012661 |
| Managed By | Davita |
| Ownership Type | Profit |
| Late Shifts | No |
| 300 Medical Center Drive, Gadsden, Alabama, 35903 | |
| (256) 492-4970 | |
News Archive
The British Association of Aesthetic Plastic Surgeons today urged caution for patients considering plastic surgery holiday packages, which generally involve having cosmetic procedures performed abroad.
A new drug could significantly slow the progression of ALS, also known as Lou Gehrig's disease, according to new research by University of Alberta biologists. Current treatments slow progression of the degenerative disease by only a few months, and these findings could revolutionize the treatment of patients suffering from ALS, extending and improving quality of life.
Precision Dynamics-TimeMed, the global leader in healthcare identification solutions, announced today that it has been awarded a combined contract for healthcare wristbands and labels by MedAssets, one of the nation's largest group purchasing organizations (GPOs).
Fatigue is the feeling of constant tiredness or weakness, which can affect anyone. In worse cases, people develop a condition called myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). This condition is debilitating and lacks a universally accepted definition, cause, diagnosis, and even treatment.
Transdel Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing topically administered products using its proprietary transdermal delivery platform, today announced positive top-line clinical results for its lead pain drug Ketotransdel®( )in a Phase 3 trial which evaluated the efficacy and safety of the drug in acute soft tissue injuries of the upper and lower extremities.
› Verified 4 days ago
| NPI Number | 1568715936 |
| Organization Name | Davita Hokes Bluff Dialysis |
| Doing Business As | Renal Treatment Centers Southeast Lp |
| Address | 300 Medical Center Dr Gadsden, Alabama, 35903 |
| Phone Number | (256) 492-4970 |
News Archive
The British Association of Aesthetic Plastic Surgeons today urged caution for patients considering plastic surgery holiday packages, which generally involve having cosmetic procedures performed abroad.
A new drug could significantly slow the progression of ALS, also known as Lou Gehrig's disease, according to new research by University of Alberta biologists. Current treatments slow progression of the degenerative disease by only a few months, and these findings could revolutionize the treatment of patients suffering from ALS, extending and improving quality of life.
Precision Dynamics-TimeMed, the global leader in healthcare identification solutions, announced today that it has been awarded a combined contract for healthcare wristbands and labels by MedAssets, one of the nation's largest group purchasing organizations (GPOs).
Fatigue is the feeling of constant tiredness or weakness, which can affect anyone. In worse cases, people develop a condition called myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). This condition is debilitating and lacks a universally accepted definition, cause, diagnosis, and even treatment.
Transdel Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing topically administered products using its proprietary transdermal delivery platform, today announced positive top-line clinical results for its lead pain drug Ketotransdel®( )in a Phase 3 trial which evaluated the efficacy and safety of the drug in acute soft tissue injuries of the upper and lower extremities.
› Verified 4 days ago
| Dialysis patients with Hemoglobin data | 15 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 7 |
News Archive
The British Association of Aesthetic Plastic Surgeons today urged caution for patients considering plastic surgery holiday packages, which generally involve having cosmetic procedures performed abroad.
A new drug could significantly slow the progression of ALS, also known as Lou Gehrig's disease, according to new research by University of Alberta biologists. Current treatments slow progression of the degenerative disease by only a few months, and these findings could revolutionize the treatment of patients suffering from ALS, extending and improving quality of life.
Precision Dynamics-TimeMed, the global leader in healthcare identification solutions, announced today that it has been awarded a combined contract for healthcare wristbands and labels by MedAssets, one of the nation's largest group purchasing organizations (GPOs).
Fatigue is the feeling of constant tiredness or weakness, which can affect anyone. In worse cases, people develop a condition called myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). This condition is debilitating and lacks a universally accepted definition, cause, diagnosis, and even treatment.
Transdel Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing topically administered products using its proprietary transdermal delivery platform, today announced positive top-line clinical results for its lead pain drug Ketotransdel®( )in a Phase 3 trial which evaluated the efficacy and safety of the drug in acute soft tissue injuries of the upper and lower extremities.
› Verified 4 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 32 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 272 |
| Percentage of adult patients getting regular hemodialysis at the center | 91 |
News Archive
The British Association of Aesthetic Plastic Surgeons today urged caution for patients considering plastic surgery holiday packages, which generally involve having cosmetic procedures performed abroad.
A new drug could significantly slow the progression of ALS, also known as Lou Gehrig's disease, according to new research by University of Alberta biologists. Current treatments slow progression of the degenerative disease by only a few months, and these findings could revolutionize the treatment of patients suffering from ALS, extending and improving quality of life.
Precision Dynamics-TimeMed, the global leader in healthcare identification solutions, announced today that it has been awarded a combined contract for healthcare wristbands and labels by MedAssets, one of the nation's largest group purchasing organizations (GPOs).
Fatigue is the feeling of constant tiredness or weakness, which can affect anyone. In worse cases, people develop a condition called myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). This condition is debilitating and lacks a universally accepted definition, cause, diagnosis, and even treatment.
Transdel Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing topically administered products using its proprietary transdermal delivery platform, today announced positive top-line clinical results for its lead pain drug Ketotransdel®( )in a Phase 3 trial which evaluated the efficacy and safety of the drug in acute soft tissue injuries of the upper and lower extremities.
› Verified 4 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Rtc-Southeast, Lp with elevated calcium levels.
| Patients with hypercalcemia | 32 |
| Hypercalcemia patient months | 273 |
| Patients with Serumphosphor | 32 |
| Patients with Serumphosphor less than 3.5 mg/dL | 14 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 29 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 32 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 18 |
| Patients with Serumphosphor greater than 7 mg/dL | 8 |
News Archive
The British Association of Aesthetic Plastic Surgeons today urged caution for patients considering plastic surgery holiday packages, which generally involve having cosmetic procedures performed abroad.
A new drug could significantly slow the progression of ALS, also known as Lou Gehrig's disease, according to new research by University of Alberta biologists. Current treatments slow progression of the degenerative disease by only a few months, and these findings could revolutionize the treatment of patients suffering from ALS, extending and improving quality of life.
Precision Dynamics-TimeMed, the global leader in healthcare identification solutions, announced today that it has been awarded a combined contract for healthcare wristbands and labels by MedAssets, one of the nation's largest group purchasing organizations (GPOs).
Fatigue is the feeling of constant tiredness or weakness, which can affect anyone. In worse cases, people develop a condition called myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). This condition is debilitating and lacks a universally accepted definition, cause, diagnosis, and even treatment.
Transdel Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing topically administered products using its proprietary transdermal delivery platform, today announced positive top-line clinical results for its lead pain drug Ketotransdel®( )in a Phase 3 trial which evaluated the efficacy and safety of the drug in acute soft tissue injuries of the upper and lower extremities.
› Verified 4 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 23 |
| Patient months included in arterial venous fistula and catheter summaries | 207 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 71 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 10 |
News Archive
The British Association of Aesthetic Plastic Surgeons today urged caution for patients considering plastic surgery holiday packages, which generally involve having cosmetic procedures performed abroad.
A new drug could significantly slow the progression of ALS, also known as Lou Gehrig's disease, according to new research by University of Alberta biologists. Current treatments slow progression of the degenerative disease by only a few months, and these findings could revolutionize the treatment of patients suffering from ALS, extending and improving quality of life.
Precision Dynamics-TimeMed, the global leader in healthcare identification solutions, announced today that it has been awarded a combined contract for healthcare wristbands and labels by MedAssets, one of the nation's largest group purchasing organizations (GPOs).
Fatigue is the feeling of constant tiredness or weakness, which can affect anyone. In worse cases, people develop a condition called myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). This condition is debilitating and lacks a universally accepted definition, cause, diagnosis, and even treatment.
Transdel Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing topically administered products using its proprietary transdermal delivery platform, today announced positive top-line clinical results for its lead pain drug Ketotransdel®( )in a Phase 3 trial which evaluated the efficacy and safety of the drug in acute soft tissue injuries of the upper and lower extremities.
› Verified 4 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 26 |
| Hospitalization Rate in facility | 165.2 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 401.8 |
| Hospitalization Rate: Lower Confidence Limit | 72.9 |
News Archive
The British Association of Aesthetic Plastic Surgeons today urged caution for patients considering plastic surgery holiday packages, which generally involve having cosmetic procedures performed abroad.
A new drug could significantly slow the progression of ALS, also known as Lou Gehrig's disease, according to new research by University of Alberta biologists. Current treatments slow progression of the degenerative disease by only a few months, and these findings could revolutionize the treatment of patients suffering from ALS, extending and improving quality of life.
Precision Dynamics-TimeMed, the global leader in healthcare identification solutions, announced today that it has been awarded a combined contract for healthcare wristbands and labels by MedAssets, one of the nation's largest group purchasing organizations (GPOs).
Fatigue is the feeling of constant tiredness or weakness, which can affect anyone. In worse cases, people develop a condition called myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). This condition is debilitating and lacks a universally accepted definition, cause, diagnosis, and even treatment.
Transdel Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing topically administered products using its proprietary transdermal delivery platform, today announced positive top-line clinical results for its lead pain drug Ketotransdel®( )in a Phase 3 trial which evaluated the efficacy and safety of the drug in acute soft tissue injuries of the upper and lower extremities.
› Verified 4 days ago
The rate of readmission show you whether patients who were being treated regularly at Rtc-Southeast, Lp were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 21.2 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 46.3 |
| Readmission Rate: Lower Confidence Limit | 6.5 |
News Archive
The British Association of Aesthetic Plastic Surgeons today urged caution for patients considering plastic surgery holiday packages, which generally involve having cosmetic procedures performed abroad.
A new drug could significantly slow the progression of ALS, also known as Lou Gehrig's disease, according to new research by University of Alberta biologists. Current treatments slow progression of the degenerative disease by only a few months, and these findings could revolutionize the treatment of patients suffering from ALS, extending and improving quality of life.
Precision Dynamics-TimeMed, the global leader in healthcare identification solutions, announced today that it has been awarded a combined contract for healthcare wristbands and labels by MedAssets, one of the nation's largest group purchasing organizations (GPOs).
Fatigue is the feeling of constant tiredness or weakness, which can affect anyone. In worse cases, people develop a condition called myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). This condition is debilitating and lacks a universally accepted definition, cause, diagnosis, and even treatment.
Transdel Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing topically administered products using its proprietary transdermal delivery platform, today announced positive top-line clinical results for its lead pain drug Ketotransdel®( )in a Phase 3 trial which evaluated the efficacy and safety of the drug in acute soft tissue injuries of the upper and lower extremities.
› Verified 4 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Rtc-Southeast, Lp get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | .97 (As Expected) |
| SIR: Upper Confidence Limit | 3.19 |
| SIR: Lower Confidence Limit | .16 |
News Archive
The British Association of Aesthetic Plastic Surgeons today urged caution for patients considering plastic surgery holiday packages, which generally involve having cosmetic procedures performed abroad.
A new drug could significantly slow the progression of ALS, also known as Lou Gehrig's disease, according to new research by University of Alberta biologists. Current treatments slow progression of the degenerative disease by only a few months, and these findings could revolutionize the treatment of patients suffering from ALS, extending and improving quality of life.
Precision Dynamics-TimeMed, the global leader in healthcare identification solutions, announced today that it has been awarded a combined contract for healthcare wristbands and labels by MedAssets, one of the nation's largest group purchasing organizations (GPOs).
Fatigue is the feeling of constant tiredness or weakness, which can affect anyone. In worse cases, people develop a condition called myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). This condition is debilitating and lacks a universally accepted definition, cause, diagnosis, and even treatment.
Transdel Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing topically administered products using its proprietary transdermal delivery platform, today announced positive top-line clinical results for its lead pain drug Ketotransdel®( )in a Phase 3 trial which evaluated the efficacy and safety of the drug in acute soft tissue injuries of the upper and lower extremities.
› Verified 4 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Rtc-Southeast, Lp's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 21 |
| Transfusion Rate in facility | 25.1 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 193.1 |
| Transfusion Rate: Lower Confidence Limit | 4.2 |
News Archive
The British Association of Aesthetic Plastic Surgeons today urged caution for patients considering plastic surgery holiday packages, which generally involve having cosmetic procedures performed abroad.
A new drug could significantly slow the progression of ALS, also known as Lou Gehrig's disease, according to new research by University of Alberta biologists. Current treatments slow progression of the degenerative disease by only a few months, and these findings could revolutionize the treatment of patients suffering from ALS, extending and improving quality of life.
Precision Dynamics-TimeMed, the global leader in healthcare identification solutions, announced today that it has been awarded a combined contract for healthcare wristbands and labels by MedAssets, one of the nation's largest group purchasing organizations (GPOs).
Fatigue is the feeling of constant tiredness or weakness, which can affect anyone. In worse cases, people develop a condition called myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). This condition is debilitating and lacks a universally accepted definition, cause, diagnosis, and even treatment.
Transdel Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing topically administered products using its proprietary transdermal delivery platform, today announced positive top-line clinical results for its lead pain drug Ketotransdel®( )in a Phase 3 trial which evaluated the efficacy and safety of the drug in acute soft tissue injuries of the upper and lower extremities.
› Verified 4 days ago
The rate of mortality show you whether patients who were being treated regularly at Rtc-Southeast, Lp lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 86 |
| Mortality Rate in facility | 17.4 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 32 |
| Mortality Rate: Lower Confidence Limit | 8.3 |
News Archive
The British Association of Aesthetic Plastic Surgeons today urged caution for patients considering plastic surgery holiday packages, which generally involve having cosmetic procedures performed abroad.
A new drug could significantly slow the progression of ALS, also known as Lou Gehrig's disease, according to new research by University of Alberta biologists. Current treatments slow progression of the degenerative disease by only a few months, and these findings could revolutionize the treatment of patients suffering from ALS, extending and improving quality of life.
Precision Dynamics-TimeMed, the global leader in healthcare identification solutions, announced today that it has been awarded a combined contract for healthcare wristbands and labels by MedAssets, one of the nation's largest group purchasing organizations (GPOs).
Fatigue is the feeling of constant tiredness or weakness, which can affect anyone. In worse cases, people develop a condition called myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). This condition is debilitating and lacks a universally accepted definition, cause, diagnosis, and even treatment.
Transdel Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing topically administered products using its proprietary transdermal delivery platform, today announced positive top-line clinical results for its lead pain drug Ketotransdel®( )in a Phase 3 trial which evaluated the efficacy and safety of the drug in acute soft tissue injuries of the upper and lower extremities.
› Verified 4 days ago
Fresenius Kidney Care Gadsden Acq, Llc Location: 800 Goodyear Avenue, Gadsden, Alabama, 35903 Phone: (256) 456-1242 |
News Archive
The British Association of Aesthetic Plastic Surgeons today urged caution for patients considering plastic surgery holiday packages, which generally involve having cosmetic procedures performed abroad.
A new drug could significantly slow the progression of ALS, also known as Lou Gehrig's disease, according to new research by University of Alberta biologists. Current treatments slow progression of the degenerative disease by only a few months, and these findings could revolutionize the treatment of patients suffering from ALS, extending and improving quality of life.
Precision Dynamics-TimeMed, the global leader in healthcare identification solutions, announced today that it has been awarded a combined contract for healthcare wristbands and labels by MedAssets, one of the nation's largest group purchasing organizations (GPOs).
Fatigue is the feeling of constant tiredness or weakness, which can affect anyone. In worse cases, people develop a condition called myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). This condition is debilitating and lacks a universally accepted definition, cause, diagnosis, and even treatment.
Transdel Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing topically administered products using its proprietary transdermal delivery platform, today announced positive top-line clinical results for its lead pain drug Ketotransdel®( )in a Phase 3 trial which evaluated the efficacy and safety of the drug in acute soft tissue injuries of the upper and lower extremities.
› Verified 4 days ago